Sign in
SBFM Stock Price, Chart, Stats & News
Sunshine Biopharma, Inc.
Save
Sunshine Biopharma, Inc. (SBFM) does not currently pay a dividend.
1.05M
Market cap
–
Current P/E
–
Forward P/E
SBFM chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 33.01% |
Operating margin | -17.35% |
Pretax margin | -17.44% |
Net margin | -16.06% |
Effective tax rate | 7.92% |
ROA | -19.03% |
ROE | -24.95% |
D/E | 0.04x |
Interest coverage ratio | -759.21x |
SBFM valuation
P/E | – |
P/S | 0.13x |
P/B | 0.20x |
P/CF | -0.67x |
P/FCF | -0.60x |
P/OCF | -0.67x |
PEG | -0.11x |
EV multiple | -2.17x |
About
Sunshine Biopharma, Inc. operates as a pharmaceutical entity and a provider of nutritional supplements, primarily dedicating its efforts to the research and development of novel anticancer therapies. A key pipeline candidate is Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin, designed to combat a broad spectrum of malignancies, including leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, and liver cancers. Notably, Adva-27a also demonstrates efficacy against multidrug-resistant cancer cells, encompassing pancreatic, breast, small-cell lung, and uterine sarcoma cells.
Similar securities
Based on sector and market capitalization
Report issue